DBV Technologies (DBVT) Exchange Rate Effect (2020 - 2026)
DBV Technologies (DBVT) posted quarterly Exchange Rate Effect of -$1.1 million for Q2 2026, down 115.28% year-on-year from $7.2 million in Q2 2025, and up 75.56% on a QoQ basis from -$4.5 million in Q1 2026.
DBV Technologies (DBVT) Exchange Rate Effect (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Exchange Rate Effect for 7 consecutive years, with -$1.1 million the latest figure, recorded in Q2 2026.
- Quarterly Exchange Rate Effect fell 115.28% year-over-year to -$1.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.2 million (down 171.65% YoY) and the FY2025 annual result came in at $8.1 million, up 289.32% from the prior year.
- Exchange Rate Effect advanced to -$1.1 million in Q2 2026 per DBVT's latest filing, from -$4.5 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for DBVT reached as high as $20.7 million in Q4 2022 and fell as low as -$14.6 million in Q3 2022.
- A 5-year average of -$132333.3 and a median of -$837500.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect soared 1132.12% — and 2026, when it slumped 1000.0%.
- Year by year, Exchange Rate Effect stood at $20.7 million in 2022, then plunged by 69.63% to $6.3 million in 2023, then plunged by 150.89% to -$3.2 million in 2024, then jumped by 136.18% to $1.2 million in 2025, then tumbled by 194.91% to -$1.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.1 million, -$4.5 million, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.10 Mn |
| Jun 30, 2026 | -1.10 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Mar 31, 2026 | -4.50 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | -779,000.00 |
| Sep 30, 2025 | -779,000.00 |
| Jun 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 7.20 Mn |
| Mar 31, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | -3.20 Mn |
| Dec 31, 2024 | -3.20 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | -896,000.00 |
| Jun 30, 2024 | -896,000.00 |
| Mar 31, 2024 | -2.96 Mn |
| Mar 31, 2024 | -2.96 Mn |